Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Odawara

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Molecular Medicine Reports|January 25, 2020
Protein kinase C promotes choline transporter‑like protein 1 function via improved cell surface expression in immortalized human hepatic cellsTakuya Ishikawa, Hirotsugu Suwanai, Junpei Shikuma, et al.
Expert Opinion on Pharmacotherapy|August 26, 2020
Real-world data on the use of insulin glargine 300 U/mL in Japanese patients with type 1 diabetes: twelve-month results from a post-marketing surveillance study (X-STAR study)Munehide Matsuhisa, Masato Odawara, Takahisa Hirose, et al.
Expert Opinion on Pharmacotherapy|July 23, 2020
Effectiveness and safety of insulin glargine 300 unit/mL in Japanese type 2 diabetes mellitus patients: a 12-month post-marketing surveillance study (X-STAR study)Masato Odawara, Munehide Matsuhisa, Takahisa Hirose, et al.
Diabetes Research and Clinical Practice|December 28, 2020
Risk of hypoglycemia in Japanese people with type 2 diabetes mellitus who initiated or switched to insulin glargine 300 U/mL: A subgroup analysis of 12-month post-marketing surveillance study (X-STAR study)Takahisa Hirose, Masato Odawara, Munehide Matsuhisa, et al.
Neuropsychiatric Disease and Treatment|August 3, 2017
Prevalence, symptomatic features, and factors associated with sleep disturbance/insomnia in Japanese patients with type-2 diabetesHajime Narisawa, Yoko Komada, Takashi Miwa, et al.
Diabetes Technology & Therapeutics|October 4, 2012
Comparison of the effects of a new 32-gauge × 4-mm pen needle and a 32-gauge × 6-mm pen needle on glycemic control, safety, and patient ratings in Japanese adults with diabetesTakashi Miwa, Rokuro Itoh, Takaaki Kobayashi, et al.
Journal of Diabetes Investigation|May 21, 2014
Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeksTakashi Kadowaki, Naoko Tajima, Masato Odawara, et al.
Diabetes, Obesity & Metabolism|December 13, 2016
Effect of race and ethnicity on vildagliptin efficacy: A pooled analysis of phase II and III studiesPlamen Kozlovski, Marilia Fonseca, Viswanathan Mohan, et al.
Pituitary|November 5, 2016
Critical review of IgG4-related hypophysitisJunpei Shikuma, Kenshi Kan, Rokuro Ito, et al.
Thyroid Research|July 11, 2021
Falsely diagnosed thyrotoxicosis caused by anti-streptavidin antibodies and pre-wash proceduresTakuya Ishikawa, Hiroyuki Sakai, Tokutaro Itaya, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Molecular Medicine Reports|January 25, 2020
Protein kinase C promotes choline transporter‑like protein 1 function via improved cell surface expression in immortalized human hepatic cellsTakuya Ishikawa, Hirotsugu Suwanai, Junpei Shikuma, et al.
Expert Opinion on Pharmacotherapy|August 26, 2020
Real-world data on the use of insulin glargine 300 U/mL in Japanese patients with type 1 diabetes: twelve-month results from a post-marketing surveillance study (X-STAR study)Munehide Matsuhisa, Masato Odawara, Takahisa Hirose, et al.
Expert Opinion on Pharmacotherapy|July 23, 2020
Effectiveness and safety of insulin glargine 300 unit/mL in Japanese type 2 diabetes mellitus patients: a 12-month post-marketing surveillance study (X-STAR study)Masato Odawara, Munehide Matsuhisa, Takahisa Hirose, et al.
Diabetes Research and Clinical Practice|December 28, 2020
Risk of hypoglycemia in Japanese people with type 2 diabetes mellitus who initiated or switched to insulin glargine 300 U/mL: A subgroup analysis of 12-month post-marketing surveillance study (X-STAR study)Takahisa Hirose, Masato Odawara, Munehide Matsuhisa, et al.
Neuropsychiatric Disease and Treatment|August 3, 2017
Prevalence, symptomatic features, and factors associated with sleep disturbance/insomnia in Japanese patients with type-2 diabetesHajime Narisawa, Yoko Komada, Takashi Miwa, et al.
Diabetes Technology & Therapeutics|October 4, 2012
Comparison of the effects of a new 32-gauge × 4-mm pen needle and a 32-gauge × 6-mm pen needle on glycemic control, safety, and patient ratings in Japanese adults with diabetesTakashi Miwa, Rokuro Itoh, Takaaki Kobayashi, et al.
Journal of Diabetes Investigation|May 21, 2014
Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeksTakashi Kadowaki, Naoko Tajima, Masato Odawara, et al.
Diabetes, Obesity & Metabolism|December 13, 2016
Effect of race and ethnicity on vildagliptin efficacy: A pooled analysis of phase II and III studiesPlamen Kozlovski, Marilia Fonseca, Viswanathan Mohan, et al.
Pituitary|November 5, 2016
Critical review of IgG4-related hypophysitisJunpei Shikuma, Kenshi Kan, Rokuro Ito, et al.
Thyroid Research|July 11, 2021
Falsely diagnosed thyrotoxicosis caused by anti-streptavidin antibodies and pre-wash proceduresTakuya Ishikawa, Hiroyuki Sakai, Tokutaro Itaya, et al.
Pageof 9